Corbus Pharmaceuticals Holdings, Inc.
CRBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $84 | $65 | $144 |
| - Cash | $27 | $20 | $19 | $17 |
| + Debt | $0 | $2 | $3 | $3 |
| Enterprise Value | – | $67 | $49 | $130 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$16 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$23 | -$18 | -$19 | -$9 |
| % Margin | – | – | – | – |
| Net Income | -$23 | -$18 | -$17 | -$10 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.9 | -1.44 | -1.39 | -0.78 |
| % Growth | -31.9% | -3.6% | -78.2% | – |
| Operating Cash Flow | -$16 | -$17 | -$16 | -$11 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$16 | -$17 | -$16 | -$11 |